RSNA 2021 Preview: Canon Medical Touts Advances Across Modalities
Learn more about what Canon Medical will be showcasing virtually at RSNA 2021.
RSNA 2021 is quickly approaching as members of the greater radiology healthcare community prepare to immerse themselves in five days of scientific sessions, key lectures, and exciting product demonstrations.
Diagnostic Imaging sat down with Canon Medical's David Hashimoto, Senior Director, Full Line BUs and Solutions Marketing, to learn more about what Canon has planned for their virtual participation in RSNA 2021.
Canon Medical will offer attendees--both in-person and virtual--an immersive experience that includes live product demonstrations and scheduled briefings with Canon Medical experts across the breadth of their portfolio, including CT, molecular imaging, MRI, ultrasound, X-ray, interventional radiology, and healthcare IT.
For the latest coverage of RSNA 2021, click here.
In addition, Canon Medical will also be hosting a roundtable discussion, "State of AI in Radiology Today," featuring a distinguished panel of speakers who will discuss the financial, technical, clinical, and regulatory considerations of applying AI in today's radiology practice and in the future.
Those interested in the roundtable discussion can pre-register here.
To learn more about what Canon Medical will be sharing at RSNA 2021, click here.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
June 22nd 2025Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
GE HealthCare Unveils Enhanced LesionID Pro at SNMMI Conference
Published: June 21st 2025 | Updated: June 21st 2025Emphasizing a zero-click experience, the updated LesionID Pro software, to be introduced at the SNMMI conference, reportedly provides AI-powered automated insights into whole-body tumor burden with PET and SPECT imaging.
